Your Trusted Student Notes
Author: Alisha G C Abstract Teclistamab is a first-in-class bispecific antibody targeting B-cell maturation antigen (BCMA) and CD3 that has significantly advanced the treatment of... Read more
Author: Alisha G C Abstract B-cell maturation antigen (BCMA) has emerged as one of the most promising therapeutic targets in multiple myeloma due to its... Read more
Author: Alisha G C Abstract B-cell maturation antigen (BCMA), also known as TNFRSF17, is a critical survival receptor expressed predominantly on plasma cells and malignant... Read more
Author: Alisha G C Abstract Bispecific antibodies represent an innovative class of engineered Immunotherapeutics capable of simultaneously binding two distinct antigens. By bridging immune effector... Read more